Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen
Martín, M., Lluch, A., Seguí, M. A., Ruiz, A., Ramos, M., Adrover, E., Rodríguez-Lescure, Á., Grosse, R., Calvo, L., Fernandez-Chacón, C., Roset, M., Antón, A., Isla, D., del Prado, P. Martínez, Iglesias, L., Zaluski, J., Arcusa, A., López-Vega, J. M., Muñoz, M., Mel, J. R.
Published in Annals of oncology (01.08.2006)
Published in Annals of oncology (01.08.2006)
Get full text
Journal Article
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004–05 study
Martín, M., Sánchez-Rovira, P., Muñoz, M., Baena-Cañada, J.M., Mel, J.R., Margeli, M., Ramos, M., Martínez, E., García-Saenz, J.A., Casado, A., Jaén, A.M., González-Farré, X., Escudero, M.J., Rodriguez-Martin, C., Carrasco, E.
Published in Annals of oncology (01.12.2011)
Published in Annals of oncology (01.12.2011)
Get full text
Journal Article
Phase ii randomised trial of raltitrexed-oxaliplatin vs raltitrexed- irinotecan as first-line treatment in advanced colorectal cancer
FELIU, J, CASTANON, C, LIZON, J, CASTRO, J, GONZALEZ-BARON, M, SALUD, A, MEL, J. R, ESCUDERO, P, PELEGRIN, A, LOPEZ-GOMEZ, L, RUIZ, M, GONZALEZ, E, JUAREZ, F
Published in British journal of cancer (28.11.2005)
Published in British journal of cancer (28.11.2005)
Get full text
Journal Article
phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
Rubio, Joaquín Casal, Vázquez, S, Vázquez, F, Amenedo, M, Fírvida, J. L, Mel, J. R, Huidobro, G, Álvarez, E, Lázaro, M, Alonso, G, Fernández, I
Published in Cancer chemotherapy and pharmacology (01.07.2009)
Published in Cancer chemotherapy and pharmacology (01.07.2009)
Get full text
Journal Article
Raltitrexed in the treatment of elderly patients with advanced colorectal cancer: an active and low toxicity regimen
Feliu, J, Mel, J.R, Camps, C, Escudero, P, Aparicio, J, Menéndez, D, Garcı́a Girón, C, Rodriguez, M.R, Sánchez, J.J, González Barón, M
Published in European journal of cancer (1990) (01.06.2002)
Published in European journal of cancer (1990) (01.06.2002)
Get full text
Journal Article
Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
ESPINOSA, E, MORALES, S, JANARIZ, J, DE LA PUENTE, M, CHECA, T, MEL, J. R, GONZALEZ BARON, M, BORREGA, P, CASAS, A, MADRONAL, C, MACHENGS, I, ILLARRAMENDI, J. A, LIZON, J, MORENO, J. A, BELON, J
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Get full text
Journal Article
Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Salvador, J., Manso, L., de la Haba, J., Jaen, A., Ciruelos, E., de Villena, M. C., Gil, M., Murias, A., Galan, A., Jara, C., Bayo, J., Baena, J. M., Casal, J., Mel, J. R., Blancas, I., Sanchez Rvira, P.
Published in Clinical & translational oncology (01.02.2015)
Published in Clinical & translational oncology (01.02.2015)
Get full text
Journal Article
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer
Vieitez, J.M, Valladares, M, Gracia, M, Gonzalez-Barón, M, Martı́n, G, Mel, J.R, Rodrı́guez, R, Constenla, M, Gómez Aldavarı́, J.L, Domı́nguez, S, Dorta, J, Garcı́a-Girón, C, López, R, Sevilla, I, Esteban, E, Antón, L.M, Peláez, I, López, E, Lacave, A.J
Published in Lung cancer (Amsterdam, Netherlands) (2003)
Published in Lung cancer (Amsterdam, Netherlands) (2003)
Get full text
Journal Article
A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia
Mel, J. R., Salar, A., Rodríguez, C. A., Alegre, A., González, A., Cassinello, J., Montesinos, J., Gasquet, J. A., Sánchez, J., Saigí, E.
Published in Current medical research and opinion (01.10.2008)
Published in Current medical research and opinion (01.10.2008)
Get full text
Journal Article
Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
Martín, Miguel, Rodríguez-Lescure, Álvaro, Ruiz, Amparo, Alba, Emilio, Calvo, Lourdes, Ruiz-Borrego, Manuel, Munárriz, Blanca, Rodríguez, César A., Crespo, Carmen, de Alava, Enrique, López García-Asenjo, José Antonio, Guitián, María Dolores, Almenar, Sergio, González-Palacios, Jesús Fernando, Vera, Francisco, Palacios, José, Ramos, Manuel, Gracia Marco, Jose Manuel, Lluch, Ana, Alvarez, Isabel, Seguí, Miguel Angel, Mayordomo, José Ignacio, Antón, Antonio, Baena, José Manuel, Plazaola, Arrate, Modolell, Alfonso, Pelegrí, Amadeu, Mel, Jose Ramón, Aranda, Enrique, Adrover, Encarna, Álvarez, José Valero, García Puche, José Luis, Sánchez-Rovira, Pedro, Gonzalez, Sonia, López-Vega, José Manuel
Published in JNCI : Journal of the National Cancer Institute (04.06.2008)
Published in JNCI : Journal of the National Cancer Institute (04.06.2008)
Get full text
Journal Article
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis
Salvador, J., Jaen, A., Ciruelos, E. M., Codes, M., Gil, M., Murias, A., Galan, A., De la Haba, J. R., Jara, C., Bayo, J. L., Baena, J. M., Casal, J., Mel, J. R., Blancas, I., Gonzalez, E., Perez, D., Manso, L.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Clinical value of circulating epithelial tumor cells and circulating endothelial cells (CTCs/CECs) in patients with HER2-negative recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) as first-line therapy
Manso, L., Ciruelos, E. M., Codes, M., De la Haba, J. R., Galan, A., Baena, J. M., Jaen, A., Gil, M., Murias, A., Blancas, I., Gonzalez, E., Perez, D., Bayo, J. L., Mel, J. R., Garcia-Martinez, E., Cubedo, R., Salvador, J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase II study of biweekly XELOX (capecitabine and oxaliplatin) as first line chemotherapy in elderly patients with metastatic colorectal cancer
Grande, C., Quintero, G., Mel, J. R., Huidobro, G., Campos, B., Candamio, S., Méndez, J. C., Salgado, M., Álvarez, E., Casal, J.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Docetaxel (D) and cisplatin (C) induction chemotherapy followed by bi-weekly D with concurrent thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC): A Galician Lung Cancer Group study
Huidobro, G., Vázquez, S., Lázaro, M., Mel, J. R., Casal, J., Castellanos, J., Vidal, Y., Fírvida, J. L., Amenedo, M.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Neoadyuvant therapy with dose-dense (DD) docetaxel (T) and doxorubicin/cyclophosphamide (AC) in locally advanced breast cancer (LABC)
Mata, J. G., Antolín, S., Mel, J. R., Ramos, M., García-Palomo, A., Almanza, M. C., De Paz, L., Martínez, L. Calvo, Álvarez, E., González-Quintas, A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Oral vinorelbine (NVBO) and gemcitabine (GEM) in elderly patients with advanced non-small-cell lung cancer (NSCLC): A phase II study conducted by the Galician Lung Cancer Group (GLCG)
Fírvida, J. L., Vazquez, S., Grande, C., Leon, L., Salgado, M., Campos, B., Lazaro, M., López, R., Pérez, E., Casal, J., Mel, J. R.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Preliminary results of docetaxel (T) and trastuzumab (H) combination administered every 21 days in metastatic breast cancer (MBC) and HER-2 over-expression patients (P)
Tusquets, I., Ramos, M., Gil, M., Sánchez-Rovira, P., Mel, J. R., Duque, A., García-Estévez, L., Velasco, A.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Multicenter phase II study of cetuximab and irinotecan as third line chemotherapy in patients (pts) with metastatic colorectal cancer (MCRC) previously treated with both irinotecan and oxaliplatin regimens
Grande, C., Mel, J. R., Salgado, M., Reboredo, M., Candamio, S., Fernandez, I., Quintero, G., Huidobro, G., Firvida, J. L., Valladares, M.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article